Related Experiment Video
Updated: May 30, 2026
08:47
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
Published on: March 3, 2023
Allergic fungal rhinosinusitis - a new staging system
C M Philpott1, A R Javer, A Clark
1St Paul`s Sinus Centre, Vancouver, British Columbia, Canada. C.Philpott@uea.ac.uk
Rhinology
|August 23, 2011
Summary
A new endoscopic staging system for allergic fungal rhinosinusitis (AFRS) offers greater sensitivity in tracking patient progress and treatment response post-surgery. This improved system allows for more detailed characterization of mucosal disease severity compared to the existing Kupferberg system.
Area of Science:
- Otolaryngology
- Endoscopic Surgery
- Rhinology
Background:
- The current Kupferberg staging system for allergic fungal rhinosinusitis (AFRS) has limitations in accurately reflecting post-operative disease persistence.
- The existing 4-stage system (0-3) may not capture localized inflammation within specific sinus cavities, leading to ineffective staging.
Purpose of the Study:
- To validate a novel, more sensitive endoscopic staging system for allergic fungal rhinosinusitis.
- To improve the characterization of mucosal inflammation and patient response to treatment post-operatively.
Main Methods:
- Retrospective staging of 50 allergic fungal rhinosinusitis patient endoscopy videos using a new ten-grade system.
- The new system scores individual sinus cavities (maxillary, ethmoid, frontal, sphenoid) for edema and fungal mucin presence.
- Inter-rater reliability was assessed with 4 independent rhinologists scoring the videos.
Main Results:
- The new system demonstrated a wider spectrum of mucosal disease, enabling more descriptive analysis of severity and treatment response.
- High inter-class correlation (0.86) was achieved among 6 total observers, indicating good reliability.
Conclusions:
- The proposed endoscopic staging system is a more sensitive tool for monitoring post-operative progress in allergic fungal rhinosinusitis.
- This system aids in accurately determining treatment efficacy and patient recovery.
Related Concept Videos
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...